US inflation and producer prices are showing easing momentum, even though inflation pressures are still significant. That puts the spotlight on companies that can grow through a slower but still inflation affected world, especially where management also has meaningful skin in the game. This article highlights why fast growing stocks with high insider ownership can appeal in this setting and reveals three standouts from the screener worth a closer look.
The stocks highlighted below are just a sample, and the full screen surfaced 106 more companies that pair rapid growth with high insider ownership and equally compelling stories not covered here. To identify and analyze the opportunities that best fit your style, head straight into the Fast Growing Stocks With High Insider Ownership screener.
Rubicon Research (NSEI:RUBICON)
Overview: Rubicon Research is a Mumbai based specialty pharmaceutical company that develops and supplies generic and specialty medicines across areas such as pain management, cardiovascular and central nervous system disorders, gastrointestinal conditions, metabolic diseases and immunosuppressants for India, the US and other markets.
Operations: Rubicon Research generates about ₹17,540 million in revenue from pharmaceutical products and related services, with almost all of it coming from the US and only a small share from India and other regions.
Market Cap: ₹268.28 billion
Rubicon Research may appeal to investors who are interested in a combination of rapid earnings growth and high insider ownership. Earnings grew 83.6% over the past year. The current P/E of 108.7x and a share price above one DCF estimate indicate relatively rich pricing. The company’s specialty focus and drug delivery platforms such as RubiReten and RubiSRL are central to its business model, while rising margins and improving ROE indicate better recent profitability. On the risk side, heavy reliance on higher risk borrowing, volatile recent share price moves and a target price below the current level suggest that investors may wish to consider position sizing and entry timing carefully.
Rubicon Research’s rapid 83.6% earnings growth, combined with a 108.7x P/E and high insider ownership, hints at a story the headline numbers do not fully explain. Get the full picture in the analysis report for Rubicon Research
Build your own high growth insider shortlist
Rubicon Research and the two other stocks in this article all surfaced from a single screen, but the real edge comes from setting filters that match your own playbook. Use our flexible Screener to combine growth, valuation, balance sheet and risk checks, or jump straight into our curated Investing Ideas for ready made starting points.
Privi Speciality Chemicals (BSE:530117)
Overview: Privi Speciality Chemicals is a Mumbai based aroma and fragrance ingredient producer that supplies a wide range of specialty chemicals used in everyday products such as detergents, shampoos, deodorants and fine fragrances to leading FMCG companies and fragrance houses in India and overseas.
Operations: Privi Speciality Chemicals generates about ₹26,711 million in revenue, almost entirely from aromatic chemicals.
Market Cap: ₹137.73 billion
Privi Speciality Chemicals provides exposure to global and Indian demand for fragrance rich consumer products, with earnings reported up 60.8% over the past year and recent Q1 FY2027 profit at ₹842.06 million on sales of ₹6,662.2 million. Capacity expansions, higher EBITDA margins and return on equity of around 23.7% indicate a business that is scaling. At the same time, the valuation is described as rich and the balance sheet leans heavily on debt, so the risk profile is elevated. An important consideration for investors is whether the company’s volume growth, incentives and product diversification will continue to support this valuation premium over time.
Privi Speciality Chemicals is scaling earnings fast while carrying a debt heavy balance sheet, which can create mispriced opportunity. See how that trade off looks across cash flows, leverage and coverage in the Privi Speciality Chemicals financial health report
Bajel Projects (NSEI:BAJEL)
Overview: Bajel Projects is an engineering, procurement and construction company that builds and upgrades power transmission and distribution infrastructure in India and overseas, handling everything from design and testing to manufacturing, installation and commissioning of high voltage lines, substations and related steel structures.
Operations: Bajel Projects generates about ₹27,508 million in revenue, all from power transmission and power distribution projects and related products.
Market Cap: ₹22.46 billion
Bajel Projects stands out in this screener because rapid earnings growth sits alongside a deep order book in power transmission, including ultra mega and mega EPC contracts with PowerGrid and large data center and international projects in Egypt. Forecast earnings and revenue growth above 50% and 25% a year respectively, plus an expected step up in return on equity from a low 3% today, point to a business that is still early in its scaling phase. At the same time, a very high P/E, thin 0.8% net margin, heavy reliance on higher risk borrowing and a relatively inexperienced board and management team raise clear questions about execution. For investors who can weigh that trade off, Bajel Projects is a high growth, high scrutiny situation worth watching closely.
Rapid earnings at Bajel Projects backed by a deep power grid order book can look exciting; yet a thin 0.8% margin and higher risk borrowing leave key questions. See how the 2 key rewards and 1 important warning sign
Curious About Alternative Stock Opportunities
Markets move fast and fresh ideas can gain breakout momentum before most investors even notice. Do not get caught watching from the sidelines while it matters. Act now.
- Spot companies quietly building momentum before headlines catch up by scanning the curated 584 high quality undiscovered gems and see which stories still sit under the radar for now.
- Lock onto resilient payers that can keep cash flowing even when sentiment drops by checking the hand picked 444 dividend fortresses for potential high yield fortresses.
- Track the picks aiming to power tomorrow’s AI build out through infrastructure by reviewing the focused 55 AI infrastructure stocks and assess which stocks match your thesis.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com